Status:

NOT_YET_RECRUITING

iTear Single-center, Open-label, Single-arm Study

Lead Sponsor:

The University of Hong Kong

Collaborating Sponsors:

ARCTIC VISION HONG KONG BIOTECH LIMITED

Conditions:

Dry Eye Disease

Dry Eye Syndromes

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This study aims to evaluate the effectiveness and safety of a device, iTEAR100 Neurostimulator (the device), which is designed to help people with Dry Eye Disease (DED) who are not satisfied with usin...

Detailed Description

This is a Phase IV, single-centre, open-label, single-arm study to evaluate the effectiveness and safety of extra nasal neurostimulation in relieving symptoms of patients with Dry Eye Disease (DED) wh...

Eligibility Criteria

Inclusion

  • Each patient must meet all the following criteria to be enrolled in this study:
  • Provided informed consent, approved by the Institutional Review Board (IRB), to participate in the study.
  • Reported use of artificial tears for DED within 30 days of Visit 1.
  • Ocular Surface Disease Index (OSDI) ≥ 23 (with no more than 3 N/A in the answers).
  • Anesthetized Schirmer Test Score ≤ 10 mm/5 min in at least one eye.

Exclusion

  • Patients who meet any of the following criteria will be excluded from the study:
  • Used extranasal or intranasal neurostimulator within 30 days of Visit 1.
  • Participation in any clinical trial with an investigational drug or device within 30 days of Visit 1.
  • In the opinion of the investigator, any condition that could impair study participation/ocular evaluation or the potential risks of participation outweigh the potential benefits.

Key Trial Info

Start Date :

August 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2026

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06525961

Start Date

August 1 2024

End Date

January 1 2026

Last Update

July 29 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong

Hong Kong, Hong Kong